Answers are grounded in this paper and cite their sources.
decreased with dose. These results suggest that R-roscovitine may influence microbial dynamics in a personalized and dose-dependent manner, supporting the inclusion of microbiome profiling as an exploratory endpoint in clinical trials.
No takes yet. Share an insight, caveat, or question.
Velo‐Suárez et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: